Bright Minds Biosciences
DRUG
64 hedge funds and large institutions have $366M invested in Bright Minds Biosciences in 2025 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 1 closing their positions.
1,700% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 1
167% more capital invested
Capital invested by funds: $137M → $366M (+$229M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
69% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 13
36% more funds holding
Funds holding: 47 → 64 (+17)
11.42% more ownership
Funds ownership: 74.34% → 85.76% (+11%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
B
Braidwell
Stamford,
Connecticut
|
+$11.8M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
+$9.71M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$7.6M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$7.26M |
| 5 |
SCM
Superstring Capital Management
New York
|
+$2.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
-$12.5M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.94M |
| 3 |
Millennium Management
New York
|
-$1.35M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.16M |
| 5 |
RAM
Readystate Asset Management
Chicago,
Illinois
|
-$365K |
DRUG Hedge Fund Activity: Q3 2025 in Review
64 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Bright Minds Biosciences (DRUG) for Q3 2025, worth a combined $366M — up 167% from $137M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new DRUG positions and 1 closed out — a net gain of 17 holders — while 22 added to existing stakes and 13 trimmed.
The largest buyer was Braidwell, opening a new position worth an estimated $11.8M. The largest seller was Sio Capital Management, cutting an estimated $12.5M.
- 64 institutional investors held Bright Minds Biosciences (DRUG) as of Q3 2025, up from 47 in Q2 2025.
- Funds reported $366M of Bright Minds Biosciences stock for Q3 2025, up 167% quarter-over-quarter.
- 18 funds opened new Bright Minds Biosciences positions in Q3 2025 and 1 closed out, a net change of +17 holders.
- The largest Bright Minds Biosciences buyer in Q3 2025 was Braidwell, an estimated $11.8M added.
- The largest Bright Minds Biosciences seller in Q3 2025 was Sio Capital Management, an estimated $12.5M sold.
Based on aggregated 13F filings for Q3 2025.